Friday, December 7, 2018

Youngevity International, Inc. (NASDAQ: YGYI) Presents at LD Micro Main Event, Co-Founder Dr. Joel Wallach Featured in Globally-Viewed Documentary


  • Youngevity representatives met one-on-one with investors at 11th annual LD Micro Main Event on Wednesday, December 5
  • Co-Founder Dr. Joel Wallach featured in documentary showcasing his impactful career of spreading health and wellness awareness across the globe
  • Online viewing of both the presentation and the documentary available
Youngevity International, Inc. (NASDAQ:YGYI), a leading omni-direct lifestyle company, presented at the 11th annual LD Micro Main Event in Los Angeles, California, on December 5. This event was the largest independent conference for small and micro-cap businesses, hosting 250 companies with attendees grossing over 1,200.

Youngevity President and Chief Financial Officer Dave Briskie led the company’s presentation, which took place at 2:00 p.m. PST on Wednesday, December 5. Company representatives attended personalized meetings with institutional investors throughout the day, allocating one-on-one time to discuss individual investor concerns.

For over 20 years since it was founded, Youngevity has continued to revolutionize its products, driven by one central question: “How can we live younger, longer?” This question, posed by its co-founder, Dr. Joel Wallach, reveals his passion for improving health and wellness for animals, people and environments all over the world.

A recent documentary on the Youngevity founder has been released by Carpe Diem Media. It is titled “The Audacity of Health: The Dr. Joel Wallach Story” and has already garnered a global following thanks to social media. The documentary traces the evolution of Wallach’s quest to spread health and wellness from the 1960s through his four decades of work in the industry. Most notably, the film showcases his early research-driven activism to save the white rhino from pollution in the 1960s, as well as his monumental victory petitioning the FDA to mandate supplement manufacturers to require important nutrients like folate, among others, as required dietary supplements. Folate, once a negligibly known substance, is now recognized as a critical component in prenatal vitamins to foster fetal health and development. The benefits of his work for the health and wellness of citizens are innumerable and far-reaching.

Youngevity CEO Steve Wallach narrated portions of the documentary. He sees the documentary (http://ibn.fm/KXN84) as a “fitting tribute” to his father, whose life’s work was to “[positively] impact…health and wellness around the world.”

Initially, the documentary was hosted on Facebook’s new “Facebook Premier” feature in an effort to reach a global audience. This post was viewed by over 30,000 people and garnered more than 1,000 comments. Viewing engagements continue to be booked. The documentary can also be viewed at JoelWallachDocumentary.com. The latest viewer statistics indicate that the documentary has already exceeded 10,000 views, covering all 50 states and over 62 countries. It can also be viewed through Youngevity.com.

Both the success of the documentary and the popularity of Youngevity’s products have allowed Dr. Joel Wallach to realize (http://ibn.fm/NbVZq) his dream – to “educate the public about the importance of proper nutrition,” hoping to reach “tens of thousands, possibly hundreds of thousands of people.”

For more information, visit the company’s website at www.YGYI.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html